[go: up one dir, main page]

AU8221291A - Cyclopentane derivatives, process for producing them and their pharmaceutical use - Google Patents

Cyclopentane derivatives, process for producing them and their pharmaceutical use

Info

Publication number
AU8221291A
AU8221291A AU82212/91A AU8221291A AU8221291A AU 8221291 A AU8221291 A AU 8221291A AU 82212/91 A AU82212/91 A AU 82212/91A AU 8221291 A AU8221291 A AU 8221291A AU 8221291 A AU8221291 A AU 8221291A
Authority
AU
Australia
Prior art keywords
producing
pharmaceutical use
cyclopentane derivatives
formula
cyclopentane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU82212/91A
Inventor
Ulrich Klar
Hartmut Rehwinkel
Karl-Heinz Thierauch
Peter Verhallen
Helmut Vorbruggen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU8221291A publication Critical patent/AU8221291A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to cyclopentane derivatives of formula (I) and their salts with physiologically tolerables bases and the $g(a), $g(b) or $g(g)-cyclodextrin clathrates and the liposome-encapsulated compounds of formula (I), a process for producing them and their pharmaceutical use.
AU82212/91A 1990-07-27 1991-07-22 Cyclopentane derivatives, process for producing them and their pharmaceutical use Abandoned AU8221291A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4024347 1990-07-27
DE4024347A DE4024347A1 (en) 1990-07-27 1990-07-27 CYCLOPENTANE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR PHARMACEUTICAL USE

Publications (1)

Publication Number Publication Date
AU8221291A true AU8221291A (en) 1992-03-02

Family

ID=6411402

Family Applications (1)

Application Number Title Priority Date Filing Date
AU82212/91A Abandoned AU8221291A (en) 1990-07-27 1991-07-22 Cyclopentane derivatives, process for producing them and their pharmaceutical use

Country Status (13)

Country Link
EP (1) EP0541594B1 (en)
JP (1) JPH06502390A (en)
AT (1) ATE122036T1 (en)
AU (1) AU8221291A (en)
CA (1) CA2088161A1 (en)
DE (3) DE4024347A1 (en)
DK (1) DK0541594T3 (en)
ES (1) ES2074721T3 (en)
IE (1) IE67507B1 (en)
IL (1) IL98970A0 (en)
PT (1) PT98464B (en)
WO (1) WO1992002495A1 (en)
ZA (1) ZA915905B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU650074B2 (en) * 1990-11-09 1994-06-09 Schering Aktiengesellschaft Berlin Und Bergkamen 9-halogen-11beta -hydroxy prostaglandin derivative, process for producing it and its use as a medicament

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU687906B2 (en) * 1993-12-15 1998-03-05 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
NZ503738A (en) * 1997-09-09 2001-05-25 Procter & Gamble Aromatic C16-20-substituted tetrahydro prostaglandin F analogues useful as FP agonists
NZ503736A (en) * 1997-09-09 2002-06-28 Procter & Gamble Aromatic C16-C20-substituted tetrahydro prostaglandins useful as FP agonists
US5977173A (en) * 1997-09-09 1999-11-02 Wos; John August Aromatic C16 -C20 -substituted tetrahydro prostaglandins useful as FP agonists
US6242493B1 (en) 1998-03-13 2001-06-05 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
WO1999047497A2 (en) * 1998-03-13 1999-09-23 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
DE60015508T2 (en) 1999-03-05 2005-04-21 Univ Durham C-16 UNAUDITED FP-SELECTIVE PROSTAGLANDIN ANALOGUE
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US7323591B2 (en) * 2006-01-10 2008-01-29 Allergan, Inc. Substituted cyclopentanes or cyclopentanones as therapeutic agents
US8592413B2 (en) 2008-05-15 2013-11-26 Allergan, Inc. Therapeutic substituted cyclopentanes
CN102336754B (en) * 2010-07-15 2017-04-12 浙江奥翔药业股份有限公司 Method for synthesizing entecavir and intermediate compound thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1431561A (en) * 1973-01-31 1976-04-07 Ici Ltd Cyclopentane derivatives
IT1053781B (en) * 1974-09-25 1981-10-10 Erba C S P A Ora Farmitalia OMEGA NOR CICLOALCIL 13.14 DEIDRO PROSTAGLANDINE
FR2349328A1 (en) * 1976-04-30 1977-11-25 Roussel Uclaf (11)-Deoxy-prostaglandin analogues - for use as hypotensives, smooth-muscle contractants and luteolytic agents
DE3126924A1 (en) * 1981-07-03 1983-01-20 Schering Ag, 1000 Berlin Und 4619 Bergkamen 9-FLUOR PROSTAGLAND DERIVATIVES, METHOD FOR THE PRODUCTION AND USE AS A MEDICINAL PRODUCT
DE3325175A1 (en) * 1983-07-08 1985-01-17 Schering AG, 1000 Berlin und 4709 Bergkamen 11-HALOGEN PROSTANE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
DE3510978A1 (en) * 1985-03-22 1986-09-25 Schering AG, Berlin und Bergkamen, 1000 Berlin NEW 9-HALOGEN PROSTAGLANDINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
ES2054860T5 (en) * 1987-07-17 2003-11-01 Schering Ag DERIVATIVES OF 9-HALOGEN- (Z) -PROSTAGLANDINAS, PROCEDURE FOR ITS PREPARATION AND ITS USE AS MEDICATIONS.
DE3923797A1 (en) * 1989-07-14 1991-01-24 Schering Ag 9-FLUOR-PROSTAGLANDIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR PHARMACEUTICAL USE

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU650074B2 (en) * 1990-11-09 1994-06-09 Schering Aktiengesellschaft Berlin Und Bergkamen 9-halogen-11beta -hydroxy prostaglandin derivative, process for producing it and its use as a medicament

Also Published As

Publication number Publication date
EP0541594B1 (en) 1995-05-03
DE4024347A1 (en) 1992-01-30
JPH06502390A (en) 1994-03-17
DE4191848D2 (en) 1993-10-07
IE67507B1 (en) 1996-04-03
CA2088161A1 (en) 1992-01-28
PT98464B (en) 1997-10-31
ZA915905B (en) 1992-04-29
ATE122036T1 (en) 1995-05-15
IE912654A1 (en) 1992-01-29
WO1992002495A1 (en) 1992-02-20
EP0541594A1 (en) 1993-05-19
IL98970A0 (en) 1992-07-15
DK0541594T3 (en) 1995-10-02
PT98464A (en) 1992-05-29
DE59105400D1 (en) 1995-06-08
ES2074721T3 (en) 1995-09-16

Similar Documents

Publication Publication Date Title
CA2216796A1 (en) Quinazoline derivatives
NO941678L (en) nor- bile acid derivatives, process for the preparation and use of them as a drug
AU8221291A (en) Cyclopentane derivatives, process for producing them and their pharmaceutical use
AU4712396A (en) Chiral methylphenyloxazolidinones
HUT68239A (en) Process for producing inclusion complexes of nimesulide alkali salts with cyclodextrins or cyclodextrin derivatives and pharmaceutical preparations containing them
AU7956291A (en) New salt form
MX9601635A (en) Anthracycline derivatives.
IL113744A0 (en) 3-Cephem derivatives and their preparation
AU8227491A (en) Cyclopentane derivatives, process for producing them and their pharmaceutical use
AU667294B2 (en) Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals
DE60111634D1 (en) PROCESS FOR THE PREPARATION OF THIAZOLIDINEDION DERIVATIVES AND INTERMEDIATE PRODUCTS
AU1192097A (en) 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties
AU2943592A (en) Leukotriene-b4 derivatives, process for preparing the same and medicaments